Last quarter (Q1 2024), Nurix Therapeutics's total revenue was $16.59M, an increase of 30.74% from the same quarter last year. In Q1, Nurix Therapeutics's net income was $-41.52M. See Nurix Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Nov 23	Nov 22	Nov 21	Nov 20	Nov 19
Total Revenue	$ 80.89M	$ 76.99M	$ 38.63M	$ 29.75M	$ 17.82M	$ 31.11M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 80.89M	$ 76.99M	$ 38.63M	$ 29.75M	-	-
Operating Expense	$ 238.22M	$ 232.05M	$ -222.49M	$ 147.64M	$ 82.80M	$ 53.35M
Operating Income	$ -157.33M	$ -155.06M	$ -183.87M	$ -117.89M	$ -64.98M	$ -22.24M
Net Non Operating Interest Income Expense	$ 12.69M	$ 11.12M	$ 3.51M	$ 823.00K	$ 1.21M	$ 776.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	$ -144.64M	$ -143.95M	$ -180.36M	$ -117.06M	$ -63.78M	$ -21.46M
Tax Provision	$ 90.00K	-	-	$ 131.00K	$ -20.54M	$ 239.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -144.73M	$ -143.95M	$ -180.36M	$ -117.19M	$ -43.24M	$ -21.70M
Basic EPS	$ -2.66	$ -2.65	$ -3.71	$ -2.73	$ -2.76	$ -1.35
Diluted EPS	$ -2.66	$ -2.65	$ -3.71	$ -2.73	$ -2.76	$ -1.35
Basic Average Shares	$ 218.23M	$ 54.34M	$ 48.61M	$ 42.90M	$ 15.67M	$ 16.11M
Diluted Average Shares	$ 218.23M	$ 54.34M	$ 48.61M	$ 42.90M	$ 15.67M	$ 16.11M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 238.22M	$ 232.05M	$ -222.49M	$ 147.64M	$ 82.80M	$ 53.35M
Net Income From Continuing And Discontinued Operation	$ -144.73M	$ -143.95M	$ -180.36M	$ -117.19M	$ -43.24M	$ -21.70M
Normalized Income	$ -122.55M	$ -113.72M	-	-	$ -43.24M	$ -21.70M
Interest Expense	-	-	-	-	-	-
EBIT	$ -144.64M	$ -143.95M	$ -180.36M	$ -117.06M	$ -64.98M	$ -22.24M
EBITDA	$ -136.85M	$ -135.75M	$ -169.18M	$ -109.27M	$ -62.80M	$ -19.88M

Currency in USD

Nurix Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing